BAR Capital is a life sciences ventural capital fund focused exclusively on companies involved in biotechnology,

pharmaceuticals,diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and 

wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $950 

million under management. Bar Capital is global leader in life sciences with principal activities in Private Equity/ 

Venture Capital, Merchant Banking . The company's over  scientific and business team, supported by its 

Advisory Boards, the strategic and financial network of its limited partners, and the close relationships developed 

with numerous life science companies and managements, provide BAR with unparalleled access and insight.

About
Company Profile
Management Team
Board of Directors
Vision & Mission
Corporate History
Capability
Capability
Advantage
Products
Drug Products
APIs
Intermediates
Fine chemicals
Investors
BAR Capital
Acorn Campus Ventures
CID Group
Orbimed
News
Company News
Media Reports
Publications
Contacts
Location & massage
Career